Back to news
Portfolio – Oct 07, 2021

Oculis Appoints Dr. Joanne Chang as Global Chief Medical Officer and Opens Hong Kong Office to broaden its footprint

Oculis S.A., (Oculis) a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, announces the appointment of Dr. Joanne Chang, M.D., Ph.D., as Chief Medical Officer and Head of Portfolio Management. Dr. Chang brings unique R&D and medical affairs expertise given her experience in multiple geographies (U.S., China and globally), as well as a deep portfolio expertise in Ophthalmology covering all key areas such as cornea, retina, and gene therapy.

See full press release here.

Latest News

Related News